Home › Funds › Citigroup Inc › ADVM
Citigroup Inc position in ADVM
ADVERUM BIOTECHNOLOGIES INC
Latest position (Q1 2025)14.75K sh
Reported value held$64.47K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 69.42K | $151.00K | New |
| Q4 2021 | 25.45K | $45.00K | Reduce |
| Q1 2022 | 5.95K | $8.00K | Reduce |
| Q2 2022 | 2.41K | $3.00K | Reduce |
| Q3 2022 | 1.19K | $1.00K | Reduce |
| Q3 2023 | 476.69K | $715.04K | New |
| Q1 2024 | 52.60K | $743.84K | New |
| Q2 2024 | 4.67K | $32.03K | Reduce |
| Q3 2024 | 15.15K | $106.34K | Add |
| Q4 2024 | 19.99K | $93.34K | Add |
| Q1 2025 | 14.75K | $64.47K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.